Featured Guests
    • Internal Medicine
    • Professor of Medicine, Epidemiology and Investigative Medicine & Humana Foundation Professor of Geriatric Medicine at Yale University
    Dr. Thomas Gill is Professor of Medicine, Epidemiology, and Investigative Medicine and the Humana Foundation Professor of Geriatric Medicine at Yale University. He received his medical degree at the University of Chicago’s Pritzker School of Medicine and his housestaff training in Internal Medicine at the University of Washington in Seattle, where he was Chief Resident. Dr. Gill received his research training in clinical epidemiology as a Robert Wood Johnson (RWJ) Clinical Scholar at Yale, and he joined the faculty in 1994 after completing an additional year as a geriatrics fellow. During the past 20 years, Dr. Gill has done groundbreaking research on the epidemiology and prevention of disability, a challenging and complex problem of immense importance to older persons, their families and society. He directs the Center on Disability and Disabling Disorders, which conducts longitudinal studies and clinical trials to enhance the scientific knowledge base of the disablement process and to rigorously evaluate promising intervention strategies. Dr. Gill is the author of more than 200 published reports and the recipient of numerous prestigious awards, including a MERIT Award and a Leadership Award from the National Institute on Aging. He holds several leadership positions at Yale, including Director of the Program on Aging and Claude D. Pepper Older Americans Independence Center and Director of the NIA-sponsored T32 postdoctoral training program in Geriatric Clinical Epidemiology and Aging-Related Research. Through the support of an NIA Midcareer Investigator Award in Patient-Oriented Research (K24) and other mechanisms, Dr. Gill has successfully mentored dozens of junior faculty, fellows and other trainees towards successful careers in geriatrics and gerontology.
    • Neurology
    Chair of Neurology, University of Alabama at Birmingham
    Chair of Neurology, University of Alabama at Birmingham
    Dr. Standaert graduated from Harvard College in 1982. He received his M.D. and Ph.D. degrees from Washington University in St. Louis. He completed a one-year internship in Medicine followed by a three-year Neurology residency at the University of Pennsylvania. He was appointed a Howard Hughes Medical Institute Physician Research Fellow, and completed a three-year research and clinical fellowship in Neurology (Movement Disorders) at Massachusetts General Hospital in 1995. He subsequently joined the faculty at Harvard Medical School and MGH, where he served as Director of the MGH/MIT Udall Center of Excellence in PD Research. Dr. Standaert relocated to the University of Alabama at Birmingham in July of 2006 and is now the John N. Whitaker Professor and Chair of the Department of Neurology. He serves as Director of the Division of Movement Disorders, the Director of the APDA Advanced Center for Parkinson Research at UAB, and Director of the UAB Bachmann-Strauss Center for Dystonia and Parkinson Disease. He sees patients in a weekly clinic and oversees many clinical trials for new treatments of Parkinson's disease. He is Chair of the Scientific Advisory Board of the American Parkinson Disease Association, a member of the Scientific Advisory Board of the Michael J. Fox Foundation for Parkinson Research, an Associate Editor of the journal Movement Disorders, and a member of the Board of Directors of the American Neurological Association. He is a member of the Board of Directors of the UAB Health System, and Chair of the UAB Health Services Foundation Advisory Committee. Dr. Standaert’s laboratory works on understanding both the root causes of Parkinson’s disease as well as the origin of the disabling symptoms that appear after long term treatment of the disease.
    • Nephrology
    • Director, Division of Nephrology / Marie S. Ingalls Endowed Chair in Nephrology leadership / Executive Vice Dean at School of Medicine at the University of Alabama at Birmingham
    Anupam Agarwal, MD is currently Director, Division of Nephrology, and Executive Vice Dean, School of Medicine at the University of Alabama at Birmingham (UAB). He also serves as the Program Director of the NIH/NIDDK funded O’Brien Center for Acute Kidney Injury Research. He also serves as the PI of a NIDDK T32 Training grant “Interdisciplinary Training in Kidney-related Research”. He has graduate faculty status in the Departments of Biochemistry and Molecular Genetics, Pathology and Cell, Developmental and Integrative Biology at UAB. Dr. Agarwal has an active role in clinical medicine, teaching, research and administration. He is intensively involved in the teaching of medical students, internal medicine house staff and nephrology fellows and has been a recipient of Outstanding Teaching Awards from the Department of Medicine at the University of Florida (2003) as well as at UAB (2005, 2007). Dr. Agarwal’s research program has provided critical insights regarding the protective nature and significance of heme oxygenase-1 (HO-1) in vascular and renal inflammation, and the molecular regulation of the human HO-1 gene. His bibliography includes 130 peer-reviewed papers and 35 invited reviews/book chapters, the former appearing in journals such as the Journal of Clinical Investigation, Journal of Experimental Medicine, Proceedings of the National Academy of Sciences, Journal of Biological Chemistry, Circulation, Circulation Research, Journal of the American Society of Nephrology, American Journal of Pathology as well as others. He has been recognized by the Max Cooper award for excellence in research, the Thomas Andreoli Professorship in Nephrology, election to membership in the American Society of Clinical Investigation (ASCI), American Clinical and Climatological Association (ACCA), Association of American Physicians (AAP) the Marie S. Ingalls Endowed Chair in Nephrology leadership, a Dean’s Excellence award for leadership and the 2013 Graduate Dean’s Excellence in Mentorship award at UAB. He is the recipient of the UAB National Alumni Society Honorary Alumnus award and a Laureate Recipient for the Alabama Chapter of the American College of Physicians (2014). He has served on the Program Committee of the American Society of Nephrology (ASN) and was the Chair of this committee for the 2013 Annual Meeting and is an elected member of the ASN Council.
    • Hematology and Oncology
    • Fellow in Hematology and Oncology at Stanford Cancer Institute
    Dr. Jason Paik is a Research Fellow in Hematology and Oncology at the Stanford Cancer Institute. He received his medical and graduate degrees through the Medical Scientist Training Program at the University of Alabama School of Medicine, where his thesis work focused on the role of the nucleolus in control of apoptosis in the context of cancer. He subsequently completed his residency training in internal medicine and clinical hematology and oncology at Stanford, where he is now working in late stage preclinical and early stage clinical translation of novel cancer immunotherapies. He also is interested in understanding the pipeline of physician scientist training in the modern era, and applying this practically for mentors and mentees.
    • Infectious Disease
    • Internal Medicine
    Dr. Kedes, who graduated with honors in Biology from Stanford University, earned his MD and PhD degrees from the MSTP at Yale University School of Medicine. He conducted his doctoral work in the laboratory of National Academy member Joan Steitz. He then completed his internal medicine residency at Stanford followed by infectious diseases and virology postdoctoral fellowships at the University of California, San Francisco, as a Howard Hughes Medical Institute Research Physician Scientist where he worked with virologist and National Academy member, Don Ganem. He joined the University of Virginia faculty in 1999 and in 2000 received a Doris Duke Clinical Scientist award and became a Pew Scholar in the Biological Sciences. He is currently a Full Professor and holds a primary appointment in the Department of Microbiology, Immunology, and Cancer Biology and a secondary appointment in the Department of Medicine, Division of Infectious Diseases and International Health. Dr. Kedes served as Associate Director of Curriculum for the UVA MSTP beginning in 2003, then held the position of Associate Director for Admissions beginning in 2009. He assumed the Directorship of the MSTP in 2014. His research group investigates the basic virology and pathogenesis of herpesviruses, with particular focus on Kaposi’s sarcoma-associated herpesvirus (KSHV), the pathogen underlying three AIDS-associated malignancies.
    • Neurology
    • Neuroscience
    MD/PhD student at University of Alabama at Birmingham
    MD/PhD student at University of Alabama at Birmingham
    Dr. Warmus received his B.S. in neuroscience with highest honors from University of California, Riverside and his Ph.D. in neurology from University of Alabama at Birmingham as part of the Medical Scientist Training Program where he is currently a fourth year medical student applying for residency in neurology. He was awarded an individual F30 fellowship from the National Institute on Aging in 2013. Additionally, he has been an active member in his local APSA chapter since its inception in 2013, and a member of Society for Neuroscience since 2006. Dr. Warmus works in Dr. Erik Roberson’s lab where their research focuses on the molecular mechanisms of neurodegenerative diseases such as Alzheimer’s disease and frontotemporal dementia (FTD). Specifically, how pathological proteins such as tau cause neuronal dysfunction and behavioral abnormalities in mouse models of the diseases in order to find potential treatment targets. Dr. Warmus studies a mouse model of FTD, and he found that mutant tau impaired the synaptic localization of NMDA receptors in selectively vulnerable brain regions, and that treatment with a drug that increases NMDA receptor function was able to correct neuronal and behavioral abnormalities in the mice.
    • Internal Medicine
    • Nephrology
    • Innovation
    • Urgent Care
    • Digital health
    • MedTech
    • Public Speaking
    • Emergency Medicine
    • Patient Work Flow
    Nephrologist, Emergency Medicine Physician, Passionate about Digital Health
    Nephrologist, Emergency Medicine Physician, Passionate about Digital Health

    Jennifer Joe, MD, is a Harvard-affiliated Massachusetts General Hospital (MGH) and Brigham and Women’s Hospital (BWH) nephrology graduate turned physician entrepreneur CEO and Founder of Medstro.com, a new and innovative social network for physicians, whose clients include The NEJM Group and Google, among others. Dr. Joe still regularly works the VA emergency room and urgent care clinics. As Editor-in-Chief of MedTech Boston and being based in Kendall Square, arguably the physical collision point of technology and academic medicine, Dr. Joe interacts and supports new medicalinnnovation and technology and has insights on best uses. In this role, she has been a mentor at the Massachusetts General Hospital-Samsung-MIT Hacking Medicine and the Tufts Medstart hackathons in the last year. She was a judge of this year’s athenahealth More Disruption Please hackathon and the Office of the National Coordinator Market R&D Pilot Challenge. Because of her insights, Dr. Joe has spoken at South by Southwest, South by Southwest V2V, Health 2.0, the Mass Medical Society EHR Conference, IN3 Medical Device 360, and the Mass TLC Healthcare Conference. Dr. Joe is also a member of the Massachusetts Medical Society Committee on IT and Committee on Communications and is the Massachusetts American College of Physicians Information Officer.